...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Liquidity

,,oooowwwww,,,telepanel,,,great idea,,,and thanks!,,,you are stirring the proverbial pot of course,,asking such a question to management!!!,,,,,hahahha,,,, it will be interesting if they do respond,,but my guess is, if they do, DM will perform his rhetoric on the subject telling us minions he and they are looking out for our best interests,,,lmao,,,,as if that's inspiring to us bag holders,,,, :o) ,,,,!!!

Share
New Message
Please login to post a reply